reports
Crescent NV: 1 director
A director at Crescent NV sold 135,000,000 shares at 0.007EUR and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
- Guy Sips
- Hilde Van Boxstael
- Jacob Mekhael
- Wim Lewi
- ING Helpdesk
Benelux Morning Notes
AEGON: Addition of €200m to existing SBB, considering US domicile, results mixed. Alfen: 19% EBITDA cut, mid-point new 2026 guidance. Flow Traders: Positive volumes, negative volatility. Kinepolis: Strong profit beat on better operating leverage, higher ticket and ITS per visitor. Recticel: Peer Rockwool 2Q25 results. Tessenderlo: Solid 1H25 beat, guidance maintained. VGP: Strong results, more news on JVs to come
- Guy Sips
- Hilde Van Boxstael
- Thibault Leneeuw
- Thomas Couvreur
- Wim Hoste
- Wim Lewi
- Guy Sips
Kinepolis Group Strong international blockbusters put leverage on prem...
We maintain our positive stance (Buy, € 50 Target Price) after 1H25 showed that strong international blockbusters put leverage on Kinepolis' premiumisation strategy. 2Q25 showed that Kinepolis' investments in experience and innovation as well as its operating model are particularly rewarding. We look forewarned to more news on further external expansion as the CEO highlighted that they are prepared for it after the new credit facility (Kinepolis closed in 1H a new € 160.0m credit line).
Strong second quarter for Kinepolis cinemas thanks to international bl...
Strong second quarter for Kinepolis cinemas thanks to international blockbusters Strong second quarter for Kinepolis cinemas thanks to international blockbusters Regulated information 21 August 2025, 7.00 am CET After a weak start to the year due to a limited blockbuster offering, Kinepolis posted strong second-quarter results, driven by a robust international film lineup and an effective premiumisation strategy. The success of ‘A Minecraft Movie’, ‘Lilo & Stitch’ and ‘Mission Impossible: The Final Reckoning’, among others, boosted visitor numbers by 17.3% in the second quarter compared...
Un deuxième trimestre solide pour les cinémas Kinepolis grâce aux bloc...
Un deuxième trimestre solide pour les cinémas Kinepolis grâce aux blockbusters internationaux Un deuxième trimestre solide pour les cinémas Kinepolis grâce aux blockbusters internationaux Information réglementée 21 août 2025, 7h00 Après un début d’année en demi-teinte, dû à une offre limitée de blockbusters, Kinepolis a enregistré de bons résultats au deuxième trimestre, portés par une offre internationale de films réussie et une stratégie de premiumisation efficace. Le succès de ‘Minecraft, le film’, ‘Lilo & Stitch’ et ‘Mission Impossible : The Final Reckoning’, entre autres, a fait gr...
Sterk tweede kwartaal voor Kinepolis-bioscopen dankzij internationale ...
Sterk tweede kwartaal voor Kinepolis-bioscopen dankzij internationale blockbusters Sterk tweede kwartaal voor Kinepolis-bioscopen dankzij internationale blockbusters Gereglementeerd bericht 21 augustus 2025, 7u00 CET Na een zwakke start van het jaar door een beperkt blockbusteraanbod, boekte Kinepolis sterke resultaten in het tweede kwartaal. Dit dankzij een succesvol internationaal filmaanbod in combinatie met een lonende premiumisatie-strategie. Het succes van onder meer ‘A Minecraft Movie’, ‘Lilo & Stitch’ en ‘Mission Impossible: The Final Reckoning’ deden het bezoekersaantal in het ...
- Livio Luyten
Sofina Cognita €6bn deal collapse impacts Sofina's 13.4% stake
A €6bn private equity deal for Cognita, a UK-based private school operator and one of Sofina's key holdings, is on the brink of collapse. Jacobs Capital, the majority shareholder, aimed to sell a significant stake in Cognita in Apr'25. The stake sale to the primary bidders, Blackstone and CVC, is now unlikely to proceed, according to the Financial Times. The deal's failure stems from a valuation mismatch and the UK's new 20% VAT on private school fees, which has introduced market uncertainty. In...
- Jacob Mekhael
- Jacob Mekhael
Onward Medical Receives FDA green light to begin pivotal ARC-IM blood ...
Onward announced that it has received FDA investigational device exemption (IDE) approval to initiate the pivotal Empower BP study with the ARC-IM implantable system to address blood pressure instability after spinal cord injury (SCI). First patient enrolment in the pivotal study is anticipated before YE25, and we look forward to the detailed interim analysis from an earlier feasibility study due later this year, as well as additional details on the pivotal study design and timelines. We reitera...
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pi...
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) The investigational device exemption (IDE) allows initiation of a global pivotal study designed to assess the safety and efficacy of the ARCIM System®, an implantable neurostimulation technology developed to address blood pressure instability after spinal cord injury (SCI).Managing blood pressure instability is a major unmet need after SCI, with a signific...
- ING Helpdesk
Euronext announces volumes for July 2025
Euronext announces volumes for July 2025 Euronext announces volumes for July 2025 Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 11 August 2025 – Euronext, the leading European capital market infrastructure, today announced trading volumes for July 2025. Monthly and historical volume tables are available at this address: CONTACTS ANALYSTS & INVESTORS – Investor Relations Aurélie Cohen Judith Stein 97 MEDIA – Europe Aurélie Cohen 45 Andrea Monzani 13 Belgium Marianne...
- Julian Dobrovolschi
- Julian Dobrovolschi
Euronext N.V.: 1 director
A director at Euronext N.V. sold 1,000 shares at 140.000EUR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
- Julian Dobrovolschi
Publication of a transparency notification
Publication of a transparency notification Kinepolis Group NVPress releaseRegulated information Publication of a transparency notification (Article 14, first paragraph, of the law of 2 May 2007 on disclosure of major holdings) 7 August 2025, 17h45 On 5 august 2025, Kinepolis Group NV has received a transparency notification from BNP Paribas Asset Management Holding, notifying that, following a transfer and an acquisition of securities with voting rights, the companies that are controlled by it own 3.06% of the voting rights attached to shares of Kinepolis Group NV, and therefore the ...
Publication relative à une notification de transparence
Publication relative à une notification de transparence Kinepolis Group SACommuniqué de presseInformation réglementée Publication relative à une notification de transparence (article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) 7 août 2025, 17h45 Le 5 août 2025, Kinepolis Group SA a reçu une notification de transparence de la part de BNP Paribas Asset Management Holding, dont il résulte que, suite à une cession et acquisition de titres conférant le droit de vote par les sociétés qu’elle contrôle, celles-ci possèdent au total 3,06% des dro...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.